| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
*
Department of Microbiology, Immunobiology Vaccine Center, University of Alabama, Birmingham, AL 35294; and
JCR Biopharmaceuticals, San Diego, CA 92121
We tested the notion that the mucosal adjuvant cholera toxin (CT) could target, in addition to nasal-associated lymphoreticular tissues, the olfactory nerves/epithelium (ON/E) and olfactory bulbs (OBs) when given intranasally. Radiolabeled CT (125I-CT) or CT-B subunit (125I-CT-B), when given intranasally to mice, entered the ON/E and OB and persisted for 6 days; however, neither molecule was present in nasal-associated lymphoreticular tissues beyond 24 h. This uptake into olfactory regions was monosialoganglioside (GM1) dependent. Intranasal vaccination with 125I-tetanus toxoid together with unlabeled CT as adjuvant resulted in uptake into the ON/E but not the OB, whereas 125I-tetanus toxoid alone did not penetrate into the CNS. We conclude that GM1-binding molecules like CT target the ON/E and are retrograde transported to the OB and may promote uptake of vaccine proteins into olfactory neurons. This raises concerns about the role of GM1-binding molecules that target neuronal tissues in mucosal immunity.
This article has been cited by other articles:
|
|
 |
|
  F. Momoi, T. Hashizume, T. Kurita-Ochiai, Y. Yuki, H. Kiyono, and M. Yamamoto Nasal Vaccination with the 40-Kilodalton Outer Membrane Protein of Porphyromonas gingivalis and a Nontoxic Chimeric Enterotoxin Adjuvant Induces Long-Term Protective Immunity with Reduced Levels of Immunoglobulin E Antibodies Infect. Immun., June 1, 2008; 76(6): 2777 - 2784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Song, H. H. Nguyen, N. Cuburu, T. Horimoto, S.-Y. Ko, S.-H. Park, C. Czerkinsky, and M.-N. Kweon From the Cover: Sublingual vaccination with influenza virus protects mice against lethal viral infection PNAS, February 5, 2008; 105(5): 1644 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. U. Bielinska, K. W. Janczak, J. J. Landers, P. Makidon, L. E. Sower, J. W. Peterson, and J. R. Baker Jr. Mucosal Immunization with a Novel Nanoemulsion-Based Recombinant Anthrax Protective Antigen Vaccine Protects against Bacillus anthracis Spore Challenge Infect. Immun., August 1, 2007; 75(8): 4020 - 4029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Becker, G. M. Bertot, D. Souss, T. Ebensen, C. A. Guzman, and S. Grinstein Intranasal Vaccination with Recombinant Outer Membrane Protein CD and Adamantylamide Dipeptide as the Mucosal Adjuvant Enhances Pulmonary Clearance of Moraxella catarrhalis in an Experimental Murine Model Infect. Immun., April 1, 2007; 75(4): 1778 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F. Nawar, S. Arce, M. W. Russell, and T. D. Connell Mutants of Type II Heat-Labile Enterotoxin LT-IIa with Altered Ganglioside-Binding Activities and Diminished Toxicity Are Potent Mucosal Adjuvants Infect. Immun., February 1, 2007; 75(2): 621 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hagiwara, Y. I. Kawamura, K. Kataoka, B. Rahima, R. J. Jackson, K. Komase, T. Dohi, P. N. Boyaka, Y. Takeda, H. Kiyono, et al. A Second Generation of Double Mutant Cholera Toxin Adjuvants: Enhanced Immunity without Intracellular Trafficking. J. Immunol., September 1, 2006; 177(5): 3045 - 3054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Zoeteweij, D. E. Epperson, J. D. Porter, C. X. Zhang, O. Y. Frolova, A. P. Constantinides, S. R. Fuhrmann, M. El-Amine, J.-H. Tian, L. R. Ellingsworth, et al. GM1 Binding-Deficient Exotoxin Is a Potent Noninflammatory Broad Spectrum Intradermal Immunoadjuvant J. Immunol., July 15, 2006; 177(2): 1197 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Stephenson, M. C. Zambon, A. Rudin, A. Colegate, A. Podda, R. Bugarini, G. del Giudice, A. Minutello, S. Bonnington, J. Holmgren, et al. Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers. J. Virol., May 1, 2006; 80(10): 4962 - 4970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Helgeby, N. C. Robson, A. M. Donachie, H. Beackock-Sharp, K. Lovgren, K. Schon, A. Mowat, and N. Y. Lycke The Combined CTA1-DD/ISCOM Adjuvant Vector Promotes Priming of Mucosal and Systemic Immunity to Incorporated Antigens by Specific Targeting of B Cells J. Immunol., March 15, 2006; 176(6): 3697 - 3706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Byrd and F. J. Cassels The encapsulation of enterotoxigenic Escherichia coli colonization factor CS3 in biodegradable microspheres enhances the murine antibody response following intranasal administration. Microbiology, March 1, 2006; 152(Pt 3): 779 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wassen and M. Jertborn Influence of Exogenous Reproductive Hormones on Specific Antibody Production in Genital Secretions after Vaginal Vaccination with Recombinant Cholera Toxin B Subunit in Humans Clin. Vaccine Immunol., February 1, 2006; 13(2): 202 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Duverger, R. J. Jackson, F. W. van Ginkel, R. Fischer, A. Tafaro, S. H. Leppla, K. Fujihashi, H. Kiyono, J. R. McGhee, and P. N. Boyaka Bacillus anthracis Edema Toxin Acts as an Adjuvant for Mucosal Immune Responses to Nasally Administered Vaccine Antigens J. Immunol., February 1, 2006; 176(3): 1776 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Lee, S. Y. Kim, B. C. Jeong, Y. R. Kim, S. J. Bae, O. S. Ahn, J.-J. Lee, H.-C. Song, J. M. Kim, H. E. Choy, et al. A Bacterial Flagellin, Vibrio vulnificus FlaB, Has a Strong Mucosal Adjuvant Activity To Induce Protective Immunity Infect. Immun., January 1, 2006; 74(1): 694 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Hajishengallis, S. Arce, C.M. Gockel, T.D. Connell, and M.W. Russell Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections Journal of Dental Research, December 1, 2005; 84(12): 1104 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W. van Ginkel, R. J. Jackson, N. Yoshino, Y. Hagiwara, D. J. Metzger, T. D. Connell, H. L. Vu, M. Martin, K. Fujihashi, and J. R. McGhee Enterotoxin-Based Mucosal Adjuvants Alter Antigen Trafficking and Induce Inflammatory Responses in the Nasal Tract Infect. Immun., October 1, 2005; 73(10): 6892 - 6902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Briles, L. Novak, M. Hotomi, F. W. van Ginkel, and J. King Nasal Colonization with Streptococcus pneumoniae Includes Subpopulations of Surface and Invasive Pneumococci Infect. Immun., October 1, 2005; 73(10): 6945 - 6951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Ko, H.-J. Ko, W.-S. Chang, S.-H. Park, M.-N. Kweon, and C.-Y. Kang {alpha}-Galactosylceramide Can Act As a Nasal Vaccine Adjuvant Inducing Protective Immune Responses against Viral Infection and Tumor J. Immunol., September 1, 2005; 175(5): 3309 - 3317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Porporatto, I. D. Bianco, and S. G. Correa Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration J. Leukoc. Biol., July 1, 2005; 78(1): 62 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kobayashi, T. Kohda, K. Kataoka, H. Ihara, S. Kozaki, D. W. Pascual, H. F. Staats, H. Kiyono, J. R. McGhee, and K. Fujihashi A Novel Neurotoxoid Vaccine Prevents Mucosal Botulism J. Immunol., February 15, 2005; 174(4): 2190 - 2195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yoshino, F. X.-S. Lu, K. Fujihashi, Y. Hagiwara, K. Kataoka, D. Lu, L. Hirst, M. Honda, F. W. van Ginkel, Y. Takeda, et al. A Novel Adjuvant for Mucosal Immunity to HIV-1 gp120 in Nonhuman Primates J. Immunol., December 1, 2004; 173(11): 6850 - 6857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Borsutzky, B. B. Cazac, J. Roes, and C. A. Guzman TGF-{beta} Receptor Signaling Is Critical for Mucosal IgA Responses J. Immunol., September 1, 2004; 173(5): 3305 - 3309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Eriksson, K. M. Schon, and N. Y. Lycke The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues J. Immunol., September 1, 2004; 173(5): 3310 - 3319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bowe, E. C. Lavelle, E. A. McNeela, C. Hale, S. Clare, B. Arico, M. M. Giuliani, A. Rae, A. Huett, R. Rappuoli, et al. Mucosal Vaccination against Serogroup B Meningococci: Induction of Bactericidal Antibodies and Cellular Immunity following Intranasal Immunization with NadA of Neisseria meningitidis and Mutants of Escherichia coli Heat-Labile Enterotoxin Infect. Immun., July 1, 2004; 72(7): 4052 - 4060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Berry, D. K. Hickey, K. A. Skelding, S. Bao, A. M. Rendina, P. M. Hansbro, C. M. Gockel, and K. W. Beagley Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects against Chlamydia muridarum Genital Tract Infection Infect. Immun., February 1, 2004; 72(2): 1019 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. W. van Ginkel, J. R. McGhee, J. M. Watt, A. Campos-Torres, L. A. Parish, and D. E. Briles Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection PNAS, November 25, 2003; 100(24): 14363 - 14367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, D. M. Hone, A. Haddad, M. T. Shata, and D. W. Pascual M Cell DNA Vaccination for CTL Immunity to HIV J. Immunol., November 1, 2003; 171(9): 4717 - 4725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Marinaro, A. Fasano, and M. T. De Magistris Zonula Occludens Toxin Acts as an Adjuvant through Different Mucosal Routes and Induces Protective Immune Responses Infect. Immun., April 1, 2003; 71(4): 1897 - 1902. [Abstract] [Full Text]
|
|
|
|
|
|
N. H. Lazarus, E. J. Kunkel, B. Johnston, E. Wilson, K. R. Youngman, and E. C. Butcher A Common Mucosal Chemokine (Mucosae-Associated Epithelial Chemokine/CCL28) Selectively Attracts IgA Plasmablasts J. Immunol., April 1, 2003; 170(7): 3799 - 3805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. Baudner, O. Balland, M. M. Giuliani, P. Von Hoegen, R. Rappuoli, D. Betbeder, and G. Del Giudice Enhancement of Protective Efficacy following Intranasal Immunization with Vaccine Plus a Nontoxic LTK63 Mutant Delivered with Nanoparticles Infect. Immun., September 1, 2002; 70(9): 4785 - 4790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Bradney, G. D. Sempowski, H.-X. Liao, B. F. Haynes, and H. F. Staats Cytokines as Adjuvants for the Induction of Anti-Human Immunodeficiency Virus Peptide Immunoglobulin G (IgG) and IgA Antibodies in Serum and Mucosal Secretions after Nasal Immunization J. Virol., January 15, 2002; 76(2): 517 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. I. Mowat, A. M. Donachie, S. Jagewall, K. Schon, B. Lowenadler, K. Dalsgaard, P. Kaastrup, and N. Lycke CTA1-DD-Immune Stimulating Complexes: a Novel, Rationally Designed Combined Mucosal Vaccine Adjuvant Effective with Nanogram Doses of Antigen J. Immunol., September 15, 2001; 167(6): 3398 - 3405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Donnelly, C. E. Loscher, M. A. Lynch, and K. H. G. Mills Whole-Cell but Not Acellular Pertussis Vaccines Induce Convulsive Activity in Mice: Evidence of a Role for Toxin-Induced Interleukin-1{beta} in a New Murine Model for Analysis of Neuronal Side Effects of Vaccination Infect. Immun., July 1, 2001; 69(7): 4217 - 4223. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
